Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this feasibility study is to identify appropriate surrogate parameters for a
randomized study to examine the efficacy of a complementary therapy with an extract of viscum
album (Iscador P) in patients with breast cancer.
Phase:
Phase 4
Details
Lead Sponsor:
Heidelberg University
Collaborators:
Verein für Krebsforschung, Arlesheim, Swizzerland Weleda AG, D-73525 Schwäbisch Gmünd